论文部分内容阅读
流行性出血热(EHF)的临床治疗方法不断改善,在按不同病期采取对症治疗的基础上,特异性治疗已逐渐受到重视。为寻求进一步的病原治疗措施,降低病死率,我们应用小剂量人α干扰素(α—IFN)和清开灵(中药注射液)联合抗病毒疗法治疗 EHF 病人,取得了较满意的疗效。现报道如下
The clinical treatment of epidemic hemorrhagic fever (EHF) continues to improve. Based on symptomatic treatment at different stages of disease, specific treatment has been gradually receiving attention. In order to seek further pathogen treatment and reduce mortality, we have achieved satisfactory results by using low-dose human interferon-alpha (IFN-α) and Qingkailing (traditional Chinese medicine injection) in combination with antiviral therapy in patients with EHF. Report as follows now